Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here. The first participants have been enrolled by Illinois-based Northwestern Medicine in a new clinical drug trial that aims to tackle coronavirus. “The drug being tested is remdesivir, a novel antiviral drug developed to treat Ebola and which has subsequently… Read More »
The internet is rife with funny cat videos showing their reactions to a plant commonly known as “catnip.” What is catnip, does it affect all felines, is it safe for cats, and should humans use it? This Special Feature investigates these questions and more. Share on PinterestDoes your feline friend go crazy for catnip? In… Read More »
At a time when germs are growing more resistant to common antibiotics, many companies that are developing new versions of the drugs are hemorrhaging money and going out of business, gravely undermining efforts to contain the spread of deadly, drug-resistant bacteria. Antibiotic start-ups like Achaogen and Aradigm have gone belly up in recent months, pharmaceutical… Read More »
Just as the Trump administration is planning to let states import prescription drugs from Canada, the United States’s northern neighbors have grown impatient with their own high drug prices. Canada is enmeshed in a drug pricing war. Canadians are paying among the highest prices in the world for drugs, prompting lawmakers to consider a major… Read More »
Speaker of the House Nancy Pelosi, December 10, 2019. Saul Loeb | AFP | Getty Images The House of Representatives on Thursday passed Speaker Nancy Pelosi‘s drug pricing legislation, a sweeping bill that will allow the U.S. government to negotiate lower prices on the costliest drugs each year. The legislation, which passed the House 230… Read More »
The cause of amyotrophic lateral sclerosis (ALS) — a disabling neurodegenerative disease that affects nerve cells in the brain and spinal cord and leads to weakened muscles and early death — is not fully understood, but accumulating evidence suggests that inflammatory processes may play a role in the initiation and progression of the condition. In… Read More »
Dive Brief: The Food and Drug Administration on Monday approved Global Blood Therapeutics’ sickle cell drug voxelotor, completing a rapid review that took the regulator about 90 days. The accelerated OK is conditional on the biotech completing a study to confirm the rise in hemoglobin measured in trials so far yields clinical benefit. Global Blood… Read More »